NEOHESPERIDIN
별칭·식별 정보
NEOHESPERIDININCINEOHESPERIDIN동의어
- cas
- 13241-33-3
- ec
- 236-216-9
- dtxsid
- DTXSID60927668
- dtxcid
- DTXCID101527365
- IUPAC
- (2S)-5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-1-benzopyran-7-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
- 분자식
- C28H34O15
- 분자량
- 610.565 g/mol
화장품에서 하는 역할
SKIN CONDITIONING
안전·규제 요약
Other restriction: ban substances that deplete the ozone layer
관련 문헌
- Valorization of residual biomass from essential oil extraction of Ammodaucus leucotrichus: A step towards sustainable cosmetic and pharmaceutical applications · 2025
- Modulation of the expression and activity of cathepsin S in reconstructed human skin by neohesperidin dihydrochalcone. · 2022
- COMPUTATIONAL ASSESSMENT OF THE PHARMACOKINETICS AND TOXICITY OF THE INTENSIVE SWEETENERS · 2021
- Repurposing FDA-approved phytomedicines, natural products, antivirals and cell protectives against SARS-CoV-2 (COVID-19) RNA-dependent RNA polymerase · 2020
- Neohesperidin suppresses IgE‐mediated anaphylactic reactions and mast cell activation via Lyn‐PLC‐Ca2+ pathway · 2019